Drug Shortage Report for BEXSERO
Report ID | 75724 |
Drug Identification Number | 02417030 |
Brand name | BEXSERO |
Common or Proper name | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | Recombinant Neisseria meningitidis group B NHBA fusion protein Recombinant Neisseria meningitidis group B NadA protein Recombinant Neisseria meningitidis group B fHBP fusion protein Outer membrane vesicles |
Strength(s) | 50MCG 50MCG 50MCG 25MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07AH |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-02-08 |
Estimated end date | 2019-04-25 |
Actual end date | 2019-03-19 |
Shortage status | Resolved |
Updated date | 2019-03-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-03-21 | French | Compare |
v6 | 2019-03-21 | English | Compare |
v5 | 2019-03-01 | French | Compare |
v4 | 2019-03-01 | English | Compare |
v3 | 2019-02-13 | French | Compare |
v2 | 2019-02-13 | French | Compare |
v1 | 2019-02-13 | English | Compare |
Showing 1 to 7 of 7